IRIS
BALDUZZI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 313
EU - Europa 176
AS - Asia 87
SA - Sud America 1
Totale 577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 312
IE - Irlanda 107
CN - Cina 72
IT - Italia 23
DE - Germania 18
FI - Finlandia 14
SG - Singapore 14
BE - Belgio 5
CZ - Repubblica Ceca 3
RU - Federazione Russa 2
SE - Svezia 2
BR - Brasile 1
CA - Canada 1
GB - Regno Unito 1
IR - Iran 1
RO - Romania 1
Totale 577
Salva come PNG Salva come JPEG
Città #
Dublin 105
Chandler 70
Ashburn 51
Shanghai 18
Boardman 17
Helsinki 13
Lawrence 13
Medford 13
Princeton 13
Nanjing 12
New York 12
Singapore 11
Beijing 10
Washington 9
Brussels 5
Munich 5
Wilmington 5
Galliate 4
Nanchang 4
Norwalk 4
Seattle 4
Brno 3
Changsha 3
Guangzhou 3
Los Angeles 3
Milan 3
Pavia 3
Shenyang 3
Ann Arbor 2
Berlin 2
Fairfield 2
Hebei 2
Jacksonville 2
Jiaxing 2
Matera 2
Monzambano 2
Shijiazhuang 2
Woodbridge 2
Chicago 1
Dallas 1
Gunzenhausen 1
Haikou 1
Hangzhou 1
Hengyang 1
London 1
Messina 1
Philadelphia 1
Piscataway 1
Saint Petersburg 1
Santa Clara 1
Serramanna 1
Toronto 1
Wuhan 1
Totale 454
Salva come PNG Salva come JPEG
Nome #
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 55
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 54
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 53
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 47
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 44
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature 41
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study 40
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis 40
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 36
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study 34
Retention rate of IL-1 inhibitors in Schnitzler's syndrome 34
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 32
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 30
Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? 26
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 21
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 11
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 9
Totale 607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 1 1 5 5 0
2020/202114 0 0 1 0 0 0 1 3 4 0 4 1
2021/202258 0 0 3 1 5 2 2 4 1 2 8 30
2022/2023253 24 26 1 9 15 19 0 14 120 1 9 15
2023/2024185 17 25 12 8 23 47 6 16 5 17 4 5
2024/202547 11 20 5 10 1 0 0 0 0 0 0 0
Totale 607